Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SMG1 CDC42BPA SZT2 VPS39 USP28 PIEZO1 SPG11 TUBGCP6 IBTK ARID1B FBXL7 ESPL1 OGA	7.33e-06	529	189	13	14621295
Pubmed	Spatacsin regulates directionality of lysosome trafficking by promoting the degradation of its partner AP5Z1.	UBR4 SPG11 KIF13A	8.67e-06	8	189	3	37871017
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HIP1 CDC42BPA SZT2 ATP13A1 VPS39 MAPKAPK2 PIEZO1 UBR4 RAPGEF1 CUL9 NCOR2 PLEKHM2 PIK3C2B SBF2 LRP3 OGDHL CABIN1 ESPL1 ENDOG	1.05e-05	1105	189	19	35748872
Pubmed	BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein.	SHANK1 FZD8 SLC16A14 DYNC1LI1 DNAH9	1.50e-05	57	189	5	27433848
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	SNX4 CDC42BPA MYO5A VEZT IFT57 CORO1C SPTBN2 PSMD13 TEX10 PPM1B NCOR2 ARID1B CSE1L SBF2 PHLPP1 STIP1 PGP PLK1	1.87e-05	1049	189	18	27880917
Pubmed	Defining the membrane proteome of NK cells.	RPL35A MYO5A ATP13A1 UBR4 ATL3 PSMD13 PARP14 TUBGCP6 NCOR2 AP1S1 CSE1L ATP8A1 SGMS1 GLE1 MARF1 DYNC1LI1 EIF3D OGA IL6ST	2.26e-05	1168	189	19	19946888
Pubmed	Gas1 Knockdown Increases the Neuroprotective Effect of Glial Cell-Derived Neurotrophic Factor Against Glutamate-Induced Cell Injury in Human SH-SY5Y Neuroblastoma Cells.	GAS1 GDNF	2.94e-05	2	189	2	26215053
Pubmed	CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer.	OPRD1 CXCR2	2.94e-05	2	189	2	18307412
Pubmed	Transcriptional regulation of mouse delta-opioid receptor gene: role of Ets-1 in the transcriptional activation of mouse delta-opioid receptor gene.	ETS1 OPRD1	2.94e-05	2	189	2	11583993
Pubmed	Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1.	CYP24A1 CSE1L	2.94e-05	2	189	2	32270348
Pubmed	Inositol pyrophosphates: between signalling and metabolism.	IP6K1 IP6K2	2.94e-05	2	189	2	23725456
Pubmed	Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.	OPRD1 OPRK1	2.94e-05	2	189	2	8393575
Pubmed	μ-Opioid receptor antibody reveals tissue-dependent specific staining and increased neuronal μ-receptor immunoreactivity at the injured nerve trunk in mice.	OPRD1 OPRK1	2.94e-05	2	189	2	24278116
Pubmed	Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases.	IP6K1 IP6K2	2.94e-05	2	189	2	10574768
Pubmed	Regulations of opioid dependence by opioid receptor types.	OPRD1 OPRK1	2.94e-05	2	189	2	11316510
Pubmed	The inositol pyrophosphate 5-InsP7 drives sodium-potassium pump degradation by relieving an autoinhibitory domain of PI3K p85α.	IP6K1 IP6K2	2.94e-05	2	189	2	33115740
Pubmed	Structure and expression of a human class pi glutathione S-transferase messenger RNA.	MYO5A GSTP1	2.94e-05	2	189	2	3664469
Pubmed	The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.	OPRD1 OPRK1	2.94e-05	2	189	2	17622222
Pubmed	CYP27A1 and CYP24 expression as a function of malignant transformation in the colon.	CYP24A1 CYP27A1	2.94e-05	2	189	2	17875655
Pubmed	Muscle stem cell renewal suppressed by Gas1 can be reversed by GDNF in mice.	GAS1 GDNF	2.94e-05	2	189	2	32021964
Pubmed	Localization of PiUS, a stimulator of cellular phosphate uptake to human chromosome 3p21.3.	IP6K1 IP6K2	2.94e-05	2	189	2	9776982
Pubmed	Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters.	SLC36A2 SLC6A20	2.94e-05	2	189	2	19033659
Pubmed	The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions.	OPRD1 OPRK1	2.94e-05	2	189	2	16331961
Pubmed	Identification of kappa- and delta-opioid receptor transcripts in immune cells.	OPRD1 OPRK1	2.94e-05	2	189	2	7649271
Pubmed	Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.	OPRD1 OPRK1	2.94e-05	2	189	2	24923251
Pubmed	Polo kinase and separase regulate the mitotic licensing of centriole duplication in human cells.	PLK1 ESPL1	2.94e-05	2	189	2	19758559
Pubmed	G-protein-coupled receptor heterodimerization modulates receptor function.	OPRD1 OPRK1	2.94e-05	2	189	2	10385123
Pubmed	The Ip6k1 and Ip6k2 Kinases Are Critical for Normal Renal Tubular Function.	IP6K1 IP6K2	2.94e-05	2	189	2	38317282
Pubmed	Association of N-acetyltransferase-2 and glutathione S-transferase polymorphisms with idiopathic male infertility in Vietnam male subjects.	NAT2 GSTP1	2.94e-05	2	189	2	29505746
Pubmed	Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer.	NAT2 GSTP1	2.94e-05	2	189	2	23523331
Pubmed	The inositol hexakisphosphate kinase family. Catalytic flexibility and function in yeast vacuole biogenesis.	IP6K1 IP6K2	2.94e-05	2	189	2	10827188
Pubmed	Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.	OPRD1 OPRK1	2.94e-05	2	189	2	16712978
Pubmed	Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice.	DRD3 SCN1A GNAT1	3.35e-05	12	189	3	8169823
Pubmed	Human transcription factor protein interaction networks.	SMG1 RPL35A CDC42BPA MYO5A CORO1C UBR4 ETS1 MSANTD2 CUL9 PSMD13 TEX10 NCOR2 ARID1B CSE1L MARF1 STIP1 TRAPPC3 EIF3D CABIN1 GABPA ZC3HAV1	3.66e-05	1429	189	21	35140242
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	CUL1 LAMB4 USP28 CORO1C PSMD13 DHX33 TEX10 OGDH CSE1L CTPS2 PHLPP1 STIP1 EIF3D PLK1 OGA TARBP1 USP47	3.84e-05	1005	189	17	19615732
Pubmed	Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women.	NAT2 DRD3 GSTP1	4.34e-05	13	189	3	20180013
Pubmed	Influence of ethnicity on pharmacogenetic variation in the Ghanaian population.	NAT2 DPYD GSTP1	4.34e-05	13	189	3	19546880
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	SHANK1 AMPD2 CDC42BPA MYO5A VEZT ATP13A1 CORO1C UBR4 PSMD13 OGDH ATL1 CSE1L SCN1A SLC4A10 DYNC1LI1 PRKAR2B STIP1 TRAPPC3	5.43e-05	1139	189	18	36417873
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	AMPD2 CLSTN3 SNX4 VEZT ATP13A1 UBR4 CD46 TEX10 CSE1L CTPS2 GLE1 DYNC1LI1 TRAPPC3 ESPL1 OGA TARBP1	6.22e-05	942	189	16	31073040
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RPL35A CDC42BPA MYO5A VEZT ATP13A1 PIEZO1 SPTBN2 UBR4 MRPL27 BCCIP DNAJC27 SPG11 PSMD13 OGDH TUBGCP6 PRKAR2B STIP1 ESPL1 OGA ENDOG ZC3HAV1	6.46e-05	1487	189	21	33957083
Pubmed	Genetic variation of genes for xenobiotic-metabolizing enzymes and risk of bronchial asthma: the importance of gene-gene and gene-environment interactions for disease susceptibility.	NAT2 UGT1A6 GSTP1	6.85e-05	15	189	3	19575027
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	MYO5A CORO1C UBR4 PSMD13 OGDH GSTP1 NCOR2 CSE1L DYNC1LI1 PRKAR2B STIP1 EIF3D ZC3HAV1	7.80e-05	665	189	13	30457570
Pubmed	Expression of the ETS transcription factor GABPα is positively correlated to the BCR-ABL1/ABL1 ratio in CML patients and affects imatinib sensitivity in vitro.	ETS1 GABPA	8.78e-05	3	189	2	26072332
Pubmed	Quantitative autoradiography of mu-,delta- and kappa1 opioid receptors in kappa-opioid receptor knockout mice.	OPRD1 OPRK1	8.78e-05	3	189	2	10082819
Pubmed	Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.	OPRD1 OPRK1	8.78e-05	3	189	2	18537939
Pubmed	Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones.	OPRD1 OPRK1	8.78e-05	3	189	2	12603260
Pubmed	The ets-related transcription factor GABP directs bidirectional transcription.	ETS1 GABPA	8.78e-05	3	189	2	18020712
Pubmed	No evidence for G-protein-coupled epsilon receptor in the brain of triple opioid receptor knockout mouse.	OPRD1 OPRK1	8.78e-05	3	189	2	15178356
Pubmed	Human atlastin GTPases mediate differentiated fusion of endoplasmic reticulum membranes.	ATL3 ATL1	8.78e-05	3	189	2	25773277
Pubmed	Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy.	DPYD GSTP1	8.78e-05	3	189	2	25677447
Pubmed	Risk factor for clear cell renal cell carcinoma in Chinese population: a case-control study.	NAT2 GSTP1	8.78e-05	3	189	2	22000673
Pubmed	Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.	OPRD1 OPRK1	8.78e-05	3	189	2	8114680
Pubmed	Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice.	OPRD1 OPRK1	8.78e-05	3	189	2	11032994
Pubmed	Systemic morphine treatment derails normal uterine receptivity, leading to embryo implantation failure in mice.	OPRD1 OPRK1	8.78e-05	3	189	2	25855262
Pubmed	Opioid receptors: from binding sites to visible molecules in vivo.	OPRD1 OPRK1	8.78e-05	3	189	2	18718480
Pubmed	The inositol hexakisphosphate kinases IP6K1 and -2 regulate human cellular phosphate homeostasis, including XPR1-mediated phosphate export.	IP6K1 IP6K2	8.78e-05	3	189	2	31186349
Pubmed	HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain.	HIP1 IFT57	8.78e-05	3	189	2	9140394
Pubmed	Multiple OPR genes influence personality traits in substance dependent and healthy subjects in two American populations.	OPRD1 OPRK1	8.78e-05	3	189	2	18213616
Pubmed	Heterodimerization of mu and delta opioid receptors: A role in opiate synergy.	OPRD1 OPRK1	8.78e-05	3	189	2	11069979
Pubmed	Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*.	OPRD1 OPRK1	8.78e-05	3	189	2	19032295
Pubmed	The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice.	OPRD1 OPRK1	8.78e-05	3	189	2	15090050
Pubmed	Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia.	OPRD1 OPRK1	8.78e-05	3	189	2	18338799
Pubmed	Identification and characterization of a novel inositol hexakisphosphate kinase.	IP6K1 IP6K2	8.78e-05	3	189	2	11502751
Pubmed	Long-term alterations in mu, delta and kappa opioidergic receptors following middle cerebral artery occlusion in mice.	OPRD1 OPRK1	8.78e-05	3	189	2	17676326
Pubmed	Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms.	OPRD1 OPRK1	8.78e-05	3	189	2	26692286
Pubmed	Vitamin D enzymes (CYP27A1, CYP27B1, and CYP24A1) and receptor expression in non-melanoma skin cancer.	CYP24A1 CYP27A1	8.78e-05	3	189	2	30668811
Pubmed	Effect of paracetamol use on the modification of the development of asthma by reactive oxygen species genes.	NAT2 GSTP1	8.78e-05	3	189	2	23622008
Pubmed	Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.	OPRD1 OPRK1	8.78e-05	3	189	2	17374034
Pubmed	Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway.	OPRD1 OPRK1	8.78e-05	3	189	2	34685631
Pubmed	Quantitative trait loci influencing morphine antinociception in four mapping populations.	MYO5A OPRK1	8.78e-05	3	189	2	11420618
Pubmed	Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu/delta/kappa-opioid receptor knockout mice reveal a nonopioid activity.	OPRD1 OPRK1	8.78e-05	3	189	2	11504820
Pubmed	Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice.	OPRD1 OPRK1	8.78e-05	3	189	2	12431223
Pubmed	The efficacy of Dynorphin fragments at the κ, μ and δ opioid receptor in transfected HEK cells and in an animal model of unilateral peripheral inflammation.	OPRD1 OPRK1	8.78e-05	3	189	2	28049031
Pubmed	CYP27A1, CYP24A1, and RXR-α Polymorphisms, Vitamin D, and Multiple Sclerosis: a Pilot Study.	CYP24A1 CYP27A1	8.78e-05	3	189	2	30088172
Pubmed	Modelling the PKPD of oxycodone in experimental pain - Impact of opioid receptor polymorphisms.	OPRD1 OPRK1	8.78e-05	3	189	2	26946441
Pubmed	Nociception increases during opioid infusion in opioid receptor triple knock-out mice.	OPRD1 OPRK1	8.78e-05	3	189	2	17544222
Pubmed	Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han.	OPRD1 OPRK1	8.78e-05	3	189	2	14745298
Pubmed	Opioid receptor characterisation of neuronally stimulated isolated human vas deferens.	OPRD1 OPRK1	8.78e-05	3	189	2	22752269
Pubmed	Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence.	OPRD1 OPRK1	8.78e-05	3	189	2	24874714
Pubmed	Age-Related Hearing Impairment Associated NAT2, GRM7, GRHL2 Susceptibility Gene Polymorphisms and Haplotypes in Roma and Hungarian Populations.	NAT2 GRM7	8.78e-05	3	189	2	29455378
Pubmed	Mammalian knock out cells reveal prominent roles for atlastin GTPases in ER network morphology.	ATL3 ATL1	8.78e-05	3	189	2	27669642
Pubmed	Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.	OPRD1 OPRK1	8.78e-05	3	189	2	11826143
Pubmed	Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site.	OPRD1 OPRK1	8.78e-05	3	189	2	33555255
Pubmed	Enhanced humoral response in kappa-opioid receptor knockout mice.	OPRD1 OPRK1	8.78e-05	3	189	2	12507774
Pubmed	Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration.	OPRD1 OPRK1	8.78e-05	3	189	2	14975676
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	SZT2 ATP13A1 VPS39 UBR4 SPG11 XRCC2 LINS1 MANF PHLPP1 MTBP STIP1 TRAPPC3 PGP CYB5R4 PLK1 OGA RAD54L CXCR2 SLC16A10	1.23e-04	1327	189	19	32694731
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	DPYD UBR4 PKD1L1 IP6K1 PSMD13 LINS1 MTBP STIP1 DNAH9	1.72e-04	361	189	9	26167880
Pubmed	Synergistic effects of NAT2 slow and GSTM1 null genotypes on carcinogen DNA damage in the lung.	NAT2 GSTP1	1.75e-04	4	189	2	20501762
Pubmed	Cell division cycle 6, a mitotic substrate of polo-like kinase 1, regulates chromosomal segregation mediated by cyclin-dependent kinase 1 and separase.	PLK1 ESPL1	1.75e-04	4	189	2	21041660
Pubmed	Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms.	ARID1B SCN1A	1.75e-04	4	189	2	26637798
Pubmed	Bifunctional apoptosis inhibitor (BAR) protects neurons from diverse cell death pathways.	HIP1 IFT57	1.75e-04	4	189	2	14502241
Pubmed	Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells.	OPRD1 OPRK1	1.75e-04	4	189	2	12413885
Pubmed	Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse.	OPRD1 OPRK1	1.75e-04	4	189	2	9502813
Pubmed	AP17 and AP19, the mammalian small chains of the clathrin-associated protein complexes show homology to Yap17p, their putative homolog in yeast.	AP1S1 AP1S2	1.75e-04	4	189	2	2040623
Pubmed	Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival.	XRCC2 RAD54L	1.75e-04	4	189	2	16540687
Pubmed	Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi.	HIP1 IFT57	1.75e-04	4	189	2	11788820
Pubmed	AP-1/σ1A and AP-1/σ1B adaptor-proteins differentially regulate neuronal early endosome maturation via the Rab5/Vps34-pathway.	AP1S1 AP1S2	1.75e-04	4	189	2	27411398
Pubmed	Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer.	NAT2 GSTP1	1.75e-04	4	189	2	15069679
Pubmed	σ1B adaptin regulates adipogenesis by mediating the sorting of sortilin in adipose tissue.	AP1S1 AP1S2	1.75e-04	4	189	2	24928897
Pubmed	Basal and induced micronucleus frequencies in human lymphocytes with different GST and NAT2 genetic backgrounds.	NAT2 GSTP1	1.75e-04	4	189	2	16621679
Interaction	ZHX1-C8orf76 interactions	UBR4 SPG11 RIC8B PRKAR2B ATG4C	3.12e-06	26	181	5	int:ZHX1-C8orf76
GeneFamily	Cadherin related	FAT4 CLSTN3 FAT3	2.00e-04	17	124	3	24
GeneFamily	Opioid receptors	OPRD1 OPRK1	2.77e-04	4	124	2	245
GeneFamily	WD repeat domain containing\|Coronins	CORO1C CORO6	9.58e-04	7	124	2	495
GeneFamily	Cullins	CUL1 CUL9	1.27e-03	8	124	2	1032
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	KLHL28 BTBD17 KLHL11 IBTK KLHL14	2.31e-03	134	124	5	861
GeneFamily	Kelch like\|BTB domain containing	KLHL28 KLHL11 KLHL14	2.97e-03	42	124	3	617
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RASA2 SPTBN2 PLEKHM2 SBF2 PHLPP1 PLEKHH2	2.98e-03	206	124	6	682
Coexpression	SENESE_HDAC3_TARGETS_UP	SMG1 KLHL28 FAT3 CD46 OGDH IFIT1 HAPLN1 FZD8 AP1S1 PAPPA TRPM8 STIP1 PLEKHH2 IL6ST MAP3K2	2.96e-06	495	187	15	M8451
Coexpression	PRC2_EZH2_UP.V1_DN	GAS1 ETS1 BCCIP MSH5 IFIT1 KLHL11 LINS1 RAD54L SLC16A10	1.04e-05	192	187	9	M2737
Coexpression	GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP	RPS6KB2 SPTBN2 XRCC2 SEC31B FZD8 PIK3C2B GLE1 EIF3D DNAH9	1.08e-05	193	187	9	M3484
Coexpression	GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	KLHL28 MAPKAPK2 CORO1C ETS1 GLE1 STIP1 TFB2M OGA CCDC107	1.44e-05	200	187	9	M7531
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	MYO5A DHX33 ACVR1B SEC31B GRM7 ATL1 EFHC2 FSIP2 ATP8A1 SCN1A SLC16A14 SBF2 ST8SIA2 CYP4X1 OGDHL PRKAR2B AP1S2 PAPPA KLHL14 KIF13A TARBP1 MAP3K2	1.44e-05	1106	187	22	M39071
Coexpression	KIM_WT1_TARGETS_12HR_DN	TMEM45A CORO1C CYP24A1 ETS1 MSANTD2 HAPLN1 RIOX2 MANF TFB2M	2.65e-05	216	187	9	M4987
Coexpression	GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	VEZT ETS1 SPG11 DHX33 IBTK SBF2 RNF145 IL6ST	3.73e-05	174	187	8	M6881
ToppCell	mild-unassigned\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP28 MSANTD2 IFIT1 OPRD1 TUBGCP6 RIC8B LGR6 CXCR2	2.23e-06	200	188	8	ca0a08bf162c954f037a56aa0cbb8b5d7c6ffec0
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	FAT4 CLSTN3 USP28 ETS1 RAPGEF1 IFIT1 LGR6 CXCR2	2.23e-06	200	188	8	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	356C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TRMT9B SMG1 KLHL11 LINS1 P2RY1 PLEKHH2 SEC14L5	5.41e-06	160	188	7	0293b244c063a62819690bf22bbc2681f8d15252
ToppCell	356C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TRMT9B SMG1 KLHL11 LINS1 P2RY1 PLEKHH2 SEC14L5	5.41e-06	160	188	7	3eaae86fa08f7651021316f8e5811bf48055591e
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMB4 FAT4 HAPLN1 PRKAR2B PAPPA PLEKHH2 IL6ST	7.75e-06	169	188	7	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IFIT1 OIT3 P2RY1 CYP4X1 PRKAR2B SMOX SEC14L5	1.09e-05	178	188	7	9e1f2596fcea5b79cc50b58d83706bb8605e224f
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IFIT1 OIT3 P2RY1 CYP4X1 PRKAR2B SMOX SEC14L5	1.09e-05	178	188	7	aa659bd283c4dfbe292cd8698bbf6b1999ca3314
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IFIT1 OIT3 P2RY1 CYP4X1 PRKAR2B SMOX SEC14L5	1.09e-05	178	188	7	bf1d273802a4f42e52ea1bd2a0cae2039559c093
ToppCell	Control-NK_activated\|Control / Disease condition and Cell class	CYP24A1 IFIT1 AXDND1 HEATR9 CYP4X1 KLHL14	1.15e-05	119	188	6	0d0bab03d56e269c6e637b0bbeffe9d1491dfc33
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	SMG1 ARID1B ATP8A1 OGA IL6ST MAP3K2 ZC3HAV1	1.21e-05	181	188	7	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac\|lymph-node_spleen / Manually curated celltypes from each tissue	VPS39 CYP27A1 KLHL11 AP1S1 CTPS2 PLK1 SLC16A10	1.25e-05	182	188	7	84018a84e1aa52fa52ccfc26db9cd1fb6d535b31
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	TRMT9B HIP1 NBEAL1 FAT3 ADAMTS9 LGR6 KIF13A	1.30e-05	183	188	7	818fd886e0188091310825f9145fa53328f2c979
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-intermediate_neuroendocrine\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TRMT9B SPTBN2 BTBD17 OPRK1 KCNH6 OGDHL UNC80	1.35e-05	184	188	7	9e5f98f9113e5e38bdadba6d9d2c346177fb35fe
ToppCell	mild-unassigned\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP28 MBOAT2 OPRD1 TUBGCP6 RIC8B LGR6 CXCR2	1.44e-05	186	188	7	5b2e1a58916f392fa1156bf9210df528775248ff
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	SMG1 PARP14 ARID1B ATP8A1 IL6ST MAP3K2 ZC3HAV1	1.55e-05	188	188	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	COPD-Epithelial-Goblet\|COPD / Disease state, Lineage and Cell class	PGLYRP4 TMEM45A CYP24A1 GPR87 KCNK1 CYP4X1 FHIP1A	1.77e-05	192	188	7	93b2ca0a97776d28c7e8f1a0642c4b63a5554aab
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DPYD RAPGEF1 ATP9B ARID1B SBF2 IL6ST SLC16A10	1.83e-05	193	188	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	HIP1 CDC42BPA PIEZO1 SPG11 PARP14 FZD8 KIF13A	1.89e-05	194	188	7	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	HIP1 CDC42BPA PIEZO1 SPG11 PARP14 FZD8 KIF13A	1.89e-05	194	188	7	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CORO1C CYP27A1 RAPGEF1 P2RY1 PLEKHM2 CYB5R4 SLC16A10	1.96e-05	195	188	7	9d649ac7d2af313481069c95349efc0c68449e2b
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SELENOP NBEAL1 ATP8A1 SCN1A HSD17B6 SLC6A20 RNF145	1.96e-05	195	188	7	d9694db6bf239636d1335016878c98f6ee2eb0eb
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	SHANK1 GAS1 CHI3L1 EPGN ADAMTS9 OGDHL PAPPA	2.23e-05	199	188	7	ca970114b5aef4518ce580897a62ac88688b2671
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DRD3 GRM7 TRIM55 SLC4A10 CYP4X1 OGDHL CORO6	2.30e-05	200	188	7	2f481e2fd248c02a5aa2e0248c16808df142fed2
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	SELENOP TMEM45A CHI3L1 LRP3 DYNC1LI1 PLEKHH2 IL6ST	2.30e-05	200	188	7	ab4fda0cc95cb8f80ea9f28745013f3248def820
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DRD3 GRM7 TRIM55 SLC4A10 CYP4X1 OGDHL CORO6	2.30e-05	200	188	7	bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SELENOP TMEM45A CHI3L1 LRP3 DYNC1LI1 PLEKHH2 IL6ST	2.30e-05	200	188	7	3bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DRD3 GRM7 TRIM55 SLC4A10 CYP4X1 OGDHL CORO6	2.30e-05	200	188	7	dc674124475edf83908b51a4e1454bc2dc4f06fa
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-OPC_related\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	SELENOP CORO1C RGS22 BTBD17 HAPLN1 TNNI3K	3.14e-05	142	188	6	d2d150e3019a5b7b143e50b1c1c2b6764abf36bf
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-OPC_related-Oligodendrocyte/OPC\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	SELENOP CORO1C RGS22 BTBD17 HAPLN1 TNNI3K	3.14e-05	142	188	6	43e72e4b9ae33768672ef90c8bbfd2ca1818c746
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCTD19 FAT3 BTBD17 MBOAT2 OIT3 IL6ST	5.12e-05	155	188	6	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCTD19 FAT3 TRPM8 PLEKHH2 DNAH9 UNC80	6.11e-05	160	188	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCTD19 FAT3 TRPM8 PLEKHH2 DNAH9 UNC80	6.11e-05	160	188	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
Disease	pancreatic cancer (is_implicated_in)	NAT2 DPYD ACVR1B XRCC2 GSTP1 MANF RAD54L	7.33e-06	112	186	7	DOID:1793 (is_implicated_in)
Disease	level of ubiquitin-like modifier-activating enzyme 7 in blood serum	IP6K1 IP6K2	3.95e-05	2	186	2	OBA_2043984
Disease	oxoglutarate dehydrogenase deficiency (implicated_via_orthology)	OGDH OGDHL	3.95e-05	2	186	2	DOID:0081326 (implicated_via_orthology)
Disease	metabolite measurement	NAT2 UGT1A6 CYP27A1 SLC36A2 TUBGCP6 GSTP1 SLC6A20 EIF3D PLEKHH2 SMOX CABIN1 DPY19L2P2 ENDOG	6.07e-05	560	186	13	EFO_0004725
Disease	hereditary spastic paraplegia 3A (implicated_via_orthology)	ATL3 ATL1	1.18e-04	3	186	2	DOID:0110791 (implicated_via_orthology)
Disease	HYPERGLYCINURIA (disorder)	SLC36A2 SLC6A20	1.18e-04	3	186	2	C0543541
Disease	Iminoglycinuria	SLC36A2 SLC6A20	2.35e-04	4	186	2	C0268654
Disease	lung non-small cell carcinoma (is_implicated_in)	CYP24A1 MSH5 ACVR1B GSTP1 ARID1B MANF	2.60e-04	139	186	6	DOID:3908 (is_implicated_in)
Disease	Cocaine Dependence	DRD3 ATP9B GDNF OPRD1 OPRK1 GSTP1	2.60e-04	139	186	6	C0600427
Disease	colorectal adenoma (is_implicated_in)	CYP24A1 GSTP1	3.90e-04	5	186	2	DOID:0050860 (is_implicated_in)
Disease	pyroglutamine measurement	MYO5A SLC36A2 SLC6A20 KCNK1	4.97e-04	58	186	4	EFO_0005408
Disease	physical activity measurement, body mass index	HIP1 RASA2 FBXL17 DNAJC27 TNNI3K	7.95e-04	114	186	5	EFO_0004340, EFO_0008002
Disease	malignant mesothelioma (is_implicated_in)	NAT2 ACVR1B	8.13e-04	7	186	2	DOID:1790 (is_implicated_in)
Disease	bacterial meningitis (is_marker_for)	CD46 CHI3L1	8.13e-04	7	186	2	DOID:9470 (is_marker_for)
Disease	Malignant Glioma	CHI3L1 GDNF GSTP1 PLK1	1.01e-03	70	186	4	C0555198
Disease	mixed gliomas	CHI3L1 GDNF GSTP1 PLK1	1.01e-03	70	186	4	C0259783
Disease	Hereditary Sensory Autonomic Neuropathy, Type 1	ATL3 ATL1	1.08e-03	8	186	2	C0020071
Disease	Middle Cerebral Artery Embolus	SMOX IL6ST CXCR2	1.28e-03	34	186	3	C0751845
Disease	Embolic Infarction, Middle Cerebral Artery	SMOX IL6ST CXCR2	1.28e-03	34	186	3	C0751847
Disease	Left Middle Cerebral Artery Infarction	SMOX IL6ST CXCR2	1.28e-03	34	186	3	C0751846
Disease	Right Middle Cerebral Artery Infarction	SMOX IL6ST CXCR2	1.28e-03	34	186	3	C0751849
Disease	Thrombotic Infarction, Middle Cerebral Artery	SMOX IL6ST CXCR2	1.28e-03	34	186	3	C0751848
Disease	Middle Cerebral Artery Occlusion	SMOX IL6ST CXCR2	1.28e-03	34	186	3	C0740391
Disease	Infarction, Middle Cerebral Artery	SMOX IL6ST CXCR2	1.28e-03	34	186	3	C0740392
Disease	Middle Cerebral Artery Thrombosis	SMOX IL6ST CXCR2	1.28e-03	34	186	3	C0740376
Disease	Middle Cerebral Artery Syndrome	SMOX IL6ST CXCR2	1.28e-03	34	186	3	C0238281
Disease	urinary bladder cancer (is_implicated_in)	NAT2 GSTP1 PLK1 CXCR2	1.38e-03	76	186	4	DOID:11054 (is_implicated_in)
Disease	Situs ambiguous	PKD1L1 DNAH9	1.38e-03	9	186	2	C1167664
Disease	multiple myeloma (is_marker_for)	CD46 CHI3L1 GSTP1	1.51e-03	36	186	3	DOID:9538 (is_marker_for)
Disease	cerebrospinal fluid biomarker measurement, alpha synuclein measurement	RAPGEF1 GABPA	1.72e-03	10	186	2	EFO_0006794, EFO_0009323
Disease	Colorectal Carcinoma	SHANK1 SELENOP DPYD CLSTN3 SPTBN2 GPR87 CD46 HAPLN1 TNNI3K CSE1L LGR6 IL6ST	1.74e-03	702	186	12	C0009402
Disease	Epilepsy, Cryptogenic	OPRD1 ARID1B SCN1A SLC4A10	1.82e-03	82	186	4	C0086237
Disease	Awakening Epilepsy	OPRD1 ARID1B SCN1A SLC4A10	1.82e-03	82	186	4	C0751111
Disease	Aura	OPRD1 ARID1B SCN1A SLC4A10	1.82e-03	82	186	4	C0236018
Disease	urate measurement, bone density	UGT1A6 ETS1 DHX33 OGDH ATL1 FSIP2 ST8SIA2 PRKAR2B CYB5R4 CABIN1 DNAH9	2.00e-03	619	186	11	EFO_0003923, EFO_0004531
Disease	Inherited neuropathies	SPTBN2 SPG11 PHYH	2.05e-03	40	186	3	C0598589
Disease	Parkinsonism (is_implicated_in)	GDNF MANF	2.09e-03	11	186	2	DOID:0080855 (is_implicated_in)
Disease	senile cataract (is_implicated_in)	NAT2 GSTP1	2.09e-03	11	186	2	DOID:9669 (is_implicated_in)
Disease	SCHIZOPHRENIA	DRD3 CHI3L1	2.09e-03	11	186	2	181500
Disease	Situs Inversus	PKD1L1 DNAH9	2.09e-03	11	186	2	C0037221
Disease	Glioma	CHI3L1 GDNF GSTP1 PLK1	2.26e-03	87	186	4	C0017638
Disease	Breast Carcinoma	NAT2 DPYD VPS39 RPS6KB2 CYP24A1 XRCC2 GSTP1 ARID1B LGR6 RAD54L	2.30e-03	538	186	10	C0678222
Disease	Huntington Disease, Late Onset	GDNF IP6K2	2.50e-03	12	186	2	C0393574
Disease	N-acetylputrescine measurement	NAT2 TUBGCP6	2.50e-03	12	186	2	EFO_0800127
Disease	Akinetic-Rigid Variant of Huntington Disease	GDNF IP6K2	2.50e-03	12	186	2	C0751207
Disease	Juvenile Huntington Disease	GDNF IP6K2	2.50e-03	12	186	2	C0751208
Disease	kynurenic acid measurement	TRMT9B PHYH	2.95e-03	13	186	2	EFO_0010506
Disease	fructose measurement	UBR4 P2RY1	2.95e-03	13	186	2	EFO_0010477
Disease	glucose measurement	TMEM45A OGDH GDNF PHYH P2RY1 PRKAR2B PLEKHH2 USP47	2.95e-03	380	186	8	EFO_0004468
Disease	social interaction measurement	DPYD IFT57 FBXL17 SLC4A10	3.00e-03	94	186	4	EFO_0009592
Disease	1-methylurate measurement	NAT2 GRM7	3.42e-03	14	186	2	EFO_0021173
Disease	Malignant neoplasm of breast	NAT2 DPYD VPS39 RPS6KB2 CYP24A1 UBR4 XRCC2 GSTP1 ARID1B HEATR9 LGR6 CYB5R4 SMOX DNAH9 RAD54L	3.45e-03	1074	186	15	C0006142
Disease	vitamin D measurement, COVID-19	UGT1A6 CYP24A1 SLC6A20	3.67e-03	49	186	3	EFO_0004631, MONDO_0100096
Disease	severe aplastic anemia	DPYD CIB4	3.93e-03	15	186	2	EFO_0006927
Disease	Anilide use measurement	MSH5 TRPM8	3.93e-03	15	186	2	EFO_0009938
Disease	Dyskinesia, Medication-Induced	DRD3 GDNF	3.93e-03	15	186	2	C0751088
Disease	Situs ambiguus	PKD1L1 DNAH9	3.93e-03	15	186	2	C0266642
Disease	Dyskinesia, Drug-Induced	DRD3 GDNF	3.93e-03	15	186	2	C0013386
Disease	type 2 diabetes mellitus (implicated_via_orthology)	RPS6KB2 ADAMTS9 CYB5R4 OGA	4.45e-03	105	186	4	DOID:9352 (implicated_via_orthology)
Disease	Peripheral Nervous System Diseases	DPYD MYO5A GSTP1	4.83e-03	54	186	3	C4721453
Disease	Huntington Disease	GDNF IP6K2	5.05e-03	17	186	2	C0020179
Disease	Liver carcinoma	NAT2 DPYD MSH5 GSTP1 ARID1B OIT3 MTBP PLK1 RAD54L	5.06e-03	507	186	9	C2239176
Disease	acute lymphoblastic leukemia (is_implicated_in)	NAT2 DPYD GSTP1	5.08e-03	55	186	3	DOID:9952 (is_implicated_in)
Disease	Epilepsy	OPRD1 ARID1B SCN1A SLC4A10	5.08e-03	109	186	4	C0014544
Disease	S-7-hydroxywarfarin measurement	TTLL2 SBF2 MTBP CCDC183	5.25e-03	110	186	4	EFO_0803329
Disease	breast carcinoma	SHANK1 AMPD2 RASA2 USP28 SPTBN2 CD46 GRM7 ARID1B P2RY1 SBF2 LGR6 KLHL14 RNF145 DPY19L2P2	5.38e-03	1019	186	14	EFO_0000305
Disease	squamous cell carcinoma (is_implicated_in)	GSTP1 MANF	5.66e-03	18	186	2	DOID:1749 (is_implicated_in)
Disease	Schizophrenia	DRD3 CHI3L1	5.66e-03	18	186	2	cv:C0036341
Disease	pneumonia, COVID-19	RGS22 RIC8B SLC6A20 UNC80	5.77e-03	113	186	4	EFO_0003106, MONDO_0100096
Disease	response to xenobiotic stimulus	UBR4 FBXL17 RAPGEF1 SGMS1 SCN1A	6.05e-03	182	186	5	GO_0009410
Disease	puberty, height growth measurement	DNAJC27 TNNI3K	6.30e-03	19	186	2	EFO_0001382, EFO_0005201
Disease	diet measurement, colorectal cancer	TRMT9B ST8SIA2	6.30e-03	19	186	2	EFO_0008111, MONDO_0005575

Protein segments in the cluster

Peptide	Gene	Start	Entry
LLSGFLVIFYCYIRK	EPGN	121	Q6UW88
ERLYKFTVTAYDCGK	CLSTN3	211	Q9BQT9
DSFKCADIYALGLVY	ACVR1B	396	P36896
LASYEKLGSTDLCYI	ATP13A1	636	Q9HD20
GACLYLVDVYAIEKS	FAT4	1701	Q6V0I7
FDKFIRYLYCGELTV	BTBD17	116	A6NE02
RYVELLDKYFGSVCE	AP1S1	86	P61966
YLCGKGDSSIRYFEI	CORO1C	281	Q9ULV4
VIEDYCTGLKALLYL	DPYD	826	Q12882
LKALRSSDKGRLCYY	GLE1	11	Q53GS7
LSGFLELLVEYFRKC	ARID1B	1746	Q8NFD5
VCLDILLYSGFVYRT	ADCY10	1381	Q96PN6
LLYSGFVYRTFEECL	ADCY10	1386	Q96PN6
GYRYETLCQELALIT	AMPD2	841	Q01433
KLRLYCKGADTVIYD	ATP8A1	566	Q9Y2Q0
YLEFVKGILSLEYCV	ATG4C	306	Q96DT6
KLLIQYRGFCAYTFA	CFAP206	411	Q8IYR0
VYYKFLEITISEARC	MSANTD2	371	Q6P1R3
RTSLYGLIKYFLCKG	NBEAL1	1071	Q6ZS30
LGSLRLNICYTEDYV	RASA2	306	Q15283
CYIYRLLSAGTIEEK	RAD54L	616	Q92698
VYELCAFLDKRDITY	KCTD19	346	Q17RG1
YVELLDKYFGSVCEL	AP1S2	86	P56377
SFLERKTVAECVLYY	NCOR2	456	Q9Y618
CYGLIVRALIYKDLD	P2RY1	236	P47900
KLACADTSRYELIIY	OR2AG2	186	A6NM03
SETCFLEYFVRYLKL	LINS1	516	Q8NG48
VDVYENLYAGRKCLL	MAPKAPK2	121	P49137
YYLIGEEILYCELKG	CD46	131	P15529
PLCSYKDYITFIEGR	MBOAT2	191	Q6ZWT7
FYSSSLLVIYDGKER	IP6K2	326	Q9UHH9
GYSLEECLEFIAIIY	GNAT1	56	P11488
FVTVVSCGLYKLKYR	HIGD1C	36	A8MV81
EIFRACLGLIYTVYV	SBF2	131	Q86WG5
SFCFLVVAGAYIKLY	LGR6	741	Q9HBX8
YCEKRFVSKYLATIG	DNAJC27	36	Q9NZQ0
TTRGDIYLLADYQCK	IBTK	356	Q9P2D0
VYKFVCDLKTLIGYS	GABPA	396	Q06546
LVISGDSLEVCLKYY	ATP9B	816	O43861
FRELYKIGITCYLLL	KCNK1	241	O00180
LLGAEECKVDILYYR	KCNH6	86	Q9H252
ILYYRKDASSFRCLV	KCNH6	96	Q9H252
CYFYLLISKTFVEAG	BCCIP	216	Q9P287
IRKFCLQYGAALIYT	DYNC1LI1	271	Q9Y6G9
IQSDTICFGRKIYYL	FSIP2	5046	Q5CZC0
ICFGRKIYYLLLEEI	FSIP2	5051	Q5CZC0
RFTKEAGTLAYYEIC	CHI3L1	286	P36222
TEVVFYGRTFKIYDC	EFHC2	156	Q5JST6
NEYYLLRGSKISRCE	F13B	426	P05160
VYRFVCDLQSLLGYT	ETS1	411	P14921
RLIFCTGKVYYDLVK	OGDHL	886	Q9ULD0
EVLKYYLIRDGCVSD	OIT3	446	Q8WWZ8
LEVFGTAYCTALYLR	PGP	96	A6NDG6
SFYIDRLKSCDIGYN	PGLYRP4	261	Q96LB8
YSGILLLACISVDRY	CXCR2	131	P25025
YLCYDVDTGRELAVK	MAP3K2	371	Q9Y2U5
LGCAFKLYSLRTQEY	LRP3	516	O75074
GLGYETKEELIFRYC	GDNF	131	P39905
LLSEVAEYGTCYTRL	TUBGCP6	396	Q96RT7
LALSRYLTYCGKVFN	GAS1	181	P54826
KLHFRILDYTLTGCY	AP5M1	431	Q9H0R1
SYYKDALRFLGCVDI	PSMD13	171	Q9UNM6
VITGLYDKCSYISRD	PAPPA	136	Q13219
ILYYCKEITLFLSAC	GPR87	291	Q9BY21
CTLIGKTLYYFRSQE	PLEKHH2	831	Q8IVE3
EVCISYLGRFYQDLK	MANF	31	P55145
FGELLCKAVLSIDYY	OPRD1	116	P41143
LKYECYLDSPLVRFL	PIK3C2B	926	O00750
YTGIVLLRCRKEFYQ	POP5	61	Q969H6
YQSEIKRLFGCYIEL	PARP14	761	Q460N5
LLFCTGKVYYDLTRE	OGDH	901	Q02218
LEKYLFSVSERGIFC	PLA2G2E	81	Q9NZK7
LSACYLFVSVGYLVR	FZD8	316	Q9H461
KYITEFLDTGYGECL	ADAMTS9	481	Q9P2N4
SACIVEYGKALDISY	FHIP1A	486	Q05DH4
FRFLLSYSIIKEYGA	ESPL1	1921	Q14674
YVLDCFAEEALKYIG	IFT57	146	Q9NWB7
YLRGNLAESKCYLIT	IL6ST	481	P40189
KFILSESAAILYYLC	GSTT4	61	A0A1W2PR19
VLSIEGAAICYYKDD	KLHL11	596	Q9NVR0
SFYACRLDKHLYVIG	KLHL14	416	Q9P2G3
TYGCRDLYLAATKYI	KLHL28	146	Q9NXS3
YCVSKYGVEAFSDIL	HSD17B6	176	O14756
TCRGLVEYFKAYIKI	ATL1	321	Q8WXF7
LYTAAVAAFVLYKCL	CCDC107	71	Q8WV48
LSDYTTCLYFICKAL	CABIN1	171	Q9Y6J0
SFESICLVLYEKRFG	CYP24A1	211	Q07973
LTDEGLRYLVIYCAS	FBXL7	311	Q9UJT9
YRFSSKVLNGICAYL	CUL1	126	Q13616
SCKITDYALIAIGRY	FBXL17	601	Q9UF56
VSGLECYDDKYTTLL	AXDND1	186	Q5T1B0
KGACVAYFLTKRREY	C14orf93	361	Q9H972
CGALEYYDKAFDRIT	EIF3D	196	O15371
FCIYDPDYAKTLLSR	CYP4X1	91	Q8N118
YFALEAICYILFEKR	CYP27A1	211	Q02318
SEVLDYELCKRFYLV	FAT3	3296	Q8TDW7
LAYCEGKLTYLADRV	CCDC183	441	Q5T5S1
SGICYRLYTEDEFEK	DHX33	411	Q9H6R0
GVEDLRCKYISLIYT	GSTP1	96	P09211
FLTLDTEGKLCYLTY	CATIP	196	Q7Z7H3
VYLCGKGDSSIRYFE	CORO6	281	Q6QEF8
VTCRGLLEYFKAYIK	ATL3	316	Q6DD88
CRVSDYGYSKLIELL	MARF1	1136	Q9Y4F3
YAISAYRLDGFKLAT	IFIT1	181	P09914
VYCLVGFILTYRKFN	NAT2	231	P11245
YSSSLLVIYDGKECR	IP6K1	331	Q92551
FYVIDRGTFDIYVKC	PRKAR2B	191	P31323
RELSYVLLTGIFLCY	GRM7	626	Q14831
LSRAQKYCILSYLEG	LAMB4	51	A4D0S4
KYEKALLRGYVESCS	CUL9	2141	Q8IWT3
YTIRGLFECDKLTYL	DNAH9	3741	Q9NYC9
KLLYYCEVLASEDFR	SEC14L5	646	O43304
TDVYLGRNKLVYICL	SLC15A5	101	A6NIM6
LLLCVIYGRFSQDEY	PKD1L1	2296	Q8TDX9
AAGILRYTDFDTLKY	DPY19L2P2	271	Q6ZN68
ELKRYYSICQDTALG	DRD3	251	P35462
GITFLTRNYCLTELY	LRRC72	81	A6NJI9
DVEVKGECSSYYLLL	MTBP	391	Q96DY7
ITDLTLEDYGRYKCE	HAPLN1	126	P10915
ETRGTRYQYCDFLVK	MED20	111	Q9H944
FRYCTLPEILKYVEC	PHYH	131	O14832
TDCYVYLLRKGATEK	PLEKHM2	631	Q8IWE5
FGDVLCKIVISIDYY	OPRK1	126	P41145
LYKTVYSALGLRDAC	MSH5	336	O43196
RISLKNIFYSCGVTY	KIF13A	1291	Q9H1H9
TGDSIRSYCEKFYLF	TAS2R60	181	P59551
KAVYYLRLLETSCSD	SZT2	2091	Q5T011
RDETEFYLGKRCAYV	RPL35A	36	P18077
EYLFYAEALRAVCRK	SNX4	306	O95219
LYSNRAACYTKLLEF	STIP1	396	P31948
AGFLYYEDLVSCVTR	DNTT	291	P04053
YAFQTGGKLYLILEC	RPS6KB2	136	Q9UBS0
ITQKYDFSFYICGLL	SLC16A14	466	Q7RTX9
RILEFYSKLGCFEIA	OGA	886	O60502
DCYFEYRLAKLVSQV	RGS22	136	Q8NE09
LCKERVDSLLKYTGY	RIC8B	431	Q9NVN3
GLAQLKSRESYVLCY	ENDOG	71	Q14249
LCIKLIASTYVYGFT	OR5AL1	156	P0C617
LYLCATYKALETVGE	SMG1	251	Q96Q15
LTEACKQYGRETLAY	HIP1	721	O00291
SVKLLYIAGILCTYA	SLC36A2	341	Q495M3
TLATRFCKQIYLYGF	ST8SIA2	301	Q92186
LYSCTSIYKFGRIEV	TFB2M	211	Q9H5Q4
SPTLRYAFYLSCKEL	NLRP7	201	Q8WX94
LAVSRALGDYDYKCV	PPM1B	196	O75688
AQRLEYLYEKLCEGT	SEC31B	1106	Q9NQW1
TGLYYRKCQLISKED	CYB5R4	271	Q7L1T6
KEYLLCFNSIGIYTD	CDC42BPA	1421	Q5VT25
CYVYGLRRFESDLKA	SLC6A20	481	Q9NP91
KDDFLIYDRCGRLVY	SELENOP	131	P49908
GECVLKLISLRHYYF	SCN1A	1586	P35498
LYNKETCARILLYRG	SHANK1	356	Q9Y566
ACPSLKIEYAFRIYD	CIB4	96	A0PJX0
YELLIYEFNLKDGRC	SPG11	111	Q96JI7
IALVGKYTKLRDCYA	CTPS2	301	Q9NRF8
DLTTIDLVAFLGYKY	YIF1B	216	Q5BJH7
LCEKFDYLYGILEER	TRIM55	211	Q9BYV6
LYCIKYGALALQEIF	CSE1L	796	P55060
YATYFDVAVLRCLLQ	UNC80	326	Q8N2C7
VYCVLRRGSLGFYKD	SPTBN2	2246	O15020
DLVLYCEAFLTTYRT	RAPGEF1	711	Q13905
LTYGALVTQLCKDYE	TRAPPC3	21	O43617
KFCKEYGLSYLSLRA	SLC4A10	581	Q6U841
KVKYEAYRTLAILGC	HEATR9	196	A2RTY3
RISLYSKNGVACYLT	SMOX	111	Q9NWM0
LYICDDGAVIFYRDK	USP47	1306	Q96K76
CYSLLYFLLTIEKGE	TEX10	801	Q9NXF1
ISRRFFCIVGTLYLY	SGMS1	211	Q86VZ5
EISLADAGTYYCVKF	SIRPD	106	Q9H106
RYKCDLRIYVCVTGF	TTLL2	251	Q9BWV7
DYSLFRKVSVYLLTG	USP28	891	Q96RU2
YYGSLFKLTDLKSLC	RIOX2	76	Q8IUF8
EIIKYCLGRFFLVYC	XRCC2	106	O43543
EECGKYFSLEGYLRR	ZNF587B	301	E7ETH6
YYHVFREGELCSLLK	TRMT9B	411	Q9P272
TLDICGYFLKALYAS	PHLPP1	866	O60346
EGKLLFYATSRAYVE	ZC3HAV1	781	Q7Z2W4
EYEVGYCERLKSFLE	PLBD2	146	Q8NHP8
IQLFSLVCTVKGYYD	PIEZO1	1251	Q92508
LKDYCLETIFYILPR	TARBP1	1351	Q13395
YSGRVIFCLDYIIFT	TRPM8	826	Q7Z2W7
LFYCLFSKYEELASA	UGT1A6	221	P19224
SACLEELKRSYEFYR	VEZT	386	Q9HBM0
NKCLYALEEGIVRYT	MRPL27	86	Q9P0M9
FLARVYEKLITGCYN	UBR4	1346	Q5T4S7
VLTLCKFYLQGYRAF	RNF145	291	Q96MT1
RYTIKADVFSYALCL	TNNI3K	641	Q59H18
RTCYLGSKTLFYRLE	TMEM45A	36	Q9NWC5
SICVGFKRDYYLIRV	VPS39	176	Q96JC1
TYRLSLLEEYGCCKE	PLK1	561	P53350
LRDKLGSYDVAFYLA	SLC16A10	441	Q8TF71
VRFIDSKLIYTYCGI	MYO5A	91	Q9Y4I1